This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Jul 2013

Serodus ASA and Phlogo ApS merger to expedite drug development

Phlogo ApS required additional resources to develop and commercialise its drug candidates SER130 and SER140.

Cardiovascular biopharma Serodus ASA and peptide specialist Phlogo ApS have announced a merger which should help the expedite the improvement and commercialisation of the potential medicines currently in development by the latter company.


Related News